Summary of Study ST002859
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001788. The data can be accessed directly via it's Project DOI: 10.21228/M8KX5C This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST002859 |
Study Title | Glucose tracing in vehicle- and Enzalutamide-treated 16D prostate cancer cells |
Study Summary | In this study, we sought to determine how Enzalutamide treatment alters metabolism in 16D prostate cancer cells. |
Institute | University of California, Los Angeles |
Laboratory | Goldstein Lab |
Last Name | Giafaglione |
First Name | Jenna |
Address | 610 Charles E Young Dr S, Los Angeles, CA, 90024, USA |
jgiafaglione@g.ucla.edu | |
Phone | 408-728-3065 |
Submit Date | 2023-09-12 |
Raw Data Available | Yes |
Raw Data File Type(s) | d |
Analysis Type Detail | GC-MS |
Release Date | 2023-09-15 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Factors:
Subject type: Cultured cells; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Treatment |
---|---|---|
SA308958 | LTEnza-3 | 10uM Enzalutamide |
SA308959 | LTEnza-2 | 10uM Enzalutamide |
SA308960 | LTEnza-1 | 10uM Enzalutamide |
SA308961 | Naive-2 | Vehicle (DMSO) |
SA308962 | Naive-3 | Vehicle (DMSO) |
SA308963 | Naive-1 | Vehicle (DMSO) |
Showing results 1 to 6 of 6 |